Literature DB >> 12047497

Reduced inositol content in lymphocyte-derived cell lines from bipolar patients.

R H Belmaker1, J Shapiro, E Vainer, L Nemanov, R P Ebstein, G Agam.   

Abstract

OBJECTIVES: The study aimed to determine whether low inositol content and uptake previously reported in brain and peripheral tissue of bipolar patients are also reflected in lymphocyte-derived cell lines from these patients.
METHODS: Inositol content and uptake were studied in lymphocyte-derived cell lines grown in vitro for at least five generations to eliminate influences of drug treatment. Inositol content was studied gas chromatographically and inositol uptake by following 3H-inositol incorporation at various concentrations.
RESULTS: Inositol levels of cell lines derived from bipolar patients were significantly lower than those of cell lines from controls.
CONCLUSIONS: Low inositol content in lymphocyte-derived cell lines from bipolar patients corroborates previous findings in frontal cortex and in lymphoblastoid cell lines and are consistent with the notion that the phosphatidylinositol signaling system is involved in the pathophysiology of this disorder.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12047497     DOI: 10.1034/j.1399-5618.2002.00108.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  4 in total

1.  Inositol synthesis regulates the activation of GSK-3α in neuronal cells.

Authors:  Cunqi Ye; Miriam L Greenberg
Journal:  J Neurochem       Date:  2014-11-17       Impact factor: 5.372

2.  Genetic inheritance of gene expression in human cell lines.

Authors:  S A Monks; A Leonardson; H Zhu; P Cundiff; P Pietrusiak; S Edwards; J W Phillips; A Sachs; E E Schadt
Journal:  Am J Hum Genet       Date:  2004-10-21       Impact factor: 11.025

3.  Effect of mood stabilizers on gene expression in lymphoblastoid cells.

Authors:  Hiroko Sugawara; Kazuya Iwamoto; Miki Bundo; Mizuho Ishiwata; Junko Ueda; Chihiro Kakiuchi; Jun Ishigooka; Tadafumi Kato
Journal:  J Neural Transm (Vienna)       Date:  2009-12-01       Impact factor: 3.575

Review 4.  Promising avenues of therapeutics for bipolar illness.

Authors:  Robert M Post
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.